期刊文献+

Survivin在膀胱移行细胞癌中的表达及其临床意义 被引量:1

The expression and clinic effect of survivin in bladder transitional cell cancer
原文传递
导出
摘要 目的比较Survivin在正常组织与膀胱移行细胞癌中表达的差异,分析其表达与膀胱移行细胞癌生物学特性及预后的关系。方法选用中山大学附属第三医院2001年至2006年间外科切除及活检的膀胱癌石蜡块标本40例,其中24例为浅表性膀胱癌组织,16例为浸润性膀胱癌组织。另取10例正常膀胱组织石蜡块标本,用免疫组化染色显示组织中Survivin表达,并对结果进行相应的统计学分析。结果10例正常膀胱组织中未见Survivin表达。于G_1级、G_2级、G_3级膀胱癌组织中Survivin的表达率分别为20%(2/10)、38.9%(7/18)、75%(9/12)。经多因素分析,Survivin的表达与膀胱癌细胞的病理分级及患者的无瘤生存时间相关,而与其肿瘤分期及生存率不相关。结论正常膀胱组织不表达Survivin。Survivin的表达率随肿瘤细胞分化程度的降低而升高。Survivin的表达水平反映患者的无瘤生存率,是预测膀胱癌复发的独立预后因子。 Objectives To compare the differential expression of Survivin in normal bladder tissue, primary bladder transitional cell carcinoma (BTCC) ; and to analysis the potential clinical significance of expression of Survivin. Methods Immunohistoehemical staining for detecting Survivin expression was carried out on 10 cases of formalin -fixed, paraffin - embedded of normal bladder tissues , 24 consecutive patients who underwent transurethral resection of bladder tumour (TURBt) for Ta, Tis, and/or T1 BTCC, and 16 consecutive patients who underwent radical cystectomy for muscle - invasive BTCC. Results Survivin was expressed in none of the 10 (0) normal bladder specimens, two of the 10(20 % ) G1 BTCC specimens, seven of the 18 (38.9%) G2 BTCC specimens, and nine of the 12 (75%) G3 BTCC specimens. Multivariable analysis revealed that Survivin expression was associated with tumor grade ( P = 0. 02) and tumor-free survival ( P = 0. 04), but not disease - specific survival ( P = 0. 09) and tumor stage (P = 0. 90). Conclusions Normal bladder tissue did not express Survivin. Expression of Survivin gradually increased with advancing tumor grade in the primary BTCC. Survivin expression was independently associated with tumor grade and tumor-free survival.
机构地区 广州市天河路
出处 《中华腔镜泌尿外科杂志(电子版)》 2008年第1期49-53,共5页 Chinese Journal of Endourology(Electronic Edition)
关键词 SURVIVIN 膀胱移行细胞癌 免疫组化 survivin bladder transitional cell cancer immunohistochemistry
  • 相关文献

参考文献11

  • 1YANG YI LI, XIAO MING LI(Laboratory of Immune Cell Biology, Division of Basic Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA).The IAP family: endogenous caspase inhibitors with multiple biological activities[J].Cell Research,2000,10(3):169-177. 被引量:20
  • 2Ambrosini G,Adida C,Altieri DC.A novel anti-apoptosis gene, Survivin, expressed in cancer and lymphoma[].Nature Medicine.1997
  • 3Tamm I,Wang Y,Sausville E,et al.IAP-family protein survivin inhibits caspase activity and apoptosis induced by fas, bax, caspases,and anticancer drugs[].Cancer Research.1998
  • 4Ku JH,Kwak C,Lee HS,et al.Expression of survivin, a novel inhibitor of apoptosis, in superficial transitional cell carcinoma of the bladder[].Journal d’Urologie.2004
  • 5Badran A,Yoshida A,Ishikawa K,et al.Identification of a novel splice variant of the human anti-apoptopsis gene survivin[].Biochemical and Biophysical Research Communications.2004
  • 6Mahotka C,Wenvel M,Springer E,et al.Survivin-deltaEX3 and Survivin-2B: two novel splice variants of the apoptosis inhibitors Survivin with different antiapoptotic properties[].Cancer Research.1999
  • 7Li F,Ambrosini G,Chu EY,et al.Control of apoptosis and mitotic spindle checkpoint by survivin[].Nature.1998
  • 8Shin S,Sung BJ,Cho YS,et al.An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and-7[].Biochemistry.2001
  • 9Suzuki A,Ito T,Kawano H,et al.Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death[].Oncegene.2000
  • 10Grabowski P,Kuhnel T,Muhr-Wilkenshoff F,et al.Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma[].British Journal of Cancer.2003

二级参考文献11

  • 1Wang C Y,Science,1998年,281卷,1680页
  • 2Chu Z L,Proc Nat Acad Sci USA,1997年,94卷,10057页
  • 3Fang S,J Bio Chem,2000年,275卷,8945页
  • 4Huang Q,Proc Nat Acad Sci SUA,2000年,97卷,1427页
  • 5Yang Y,Science,2000年,288卷,874页
  • 6Chen Z,Biochem Biolphys Res Commun,1999年,264卷,847页
  • 7Li F,Nat Cell Biol,1999年,1卷,461页
  • 8Sun C,Nature,1999年,4O1卷,818页
  • 9Joazeiro C A,Science,1999年,286卷,309页
  • 10Tamm I,Cancer Res,1998年,58卷,5315页

共引文献19

同被引文献7

  • 1关维民,杨宝龙.存活素与泌尿系肿瘤研究进展[J].中华泌尿外科杂志,2004,25(10):714-716. 被引量:2
  • 2Dohi T, Okada K, Xia F, et al. An IAP-IAP complex inhibits apoptosis. J Biol Chem, 2004, 279: 34087-34090.
  • 3Lehner R, Lucia MS, Jarboe EA, et al. Immunohistochemical localization of the IAP protein survivin in bladder mucosa and transitional cell carcinoma. Appl /mmunohistochem Mol Morphol, 2002, 10: 134-138.
  • 4Blanc-Brude OP, Mesri M, Wall NR, et al. Therapeutic targeting of the Survivin pathway in cancer: Initiation of mitochondrial apoptosis and suppression of tumor-associated angio- genesis. Clin Cancer Res, 2003, 9: 2683 -2692.
  • 5Swana HS, Grossman D, Anthony JN, et al. Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med, 1999, 341: 452-453.
  • 6Ku JH, Kwak C, Lee HS, et al. Expression of surviving, a noval inhibitor of apoptosis, in superficial transitional cell carcinoma of the bladder. J Urol, 2004, 171(2 pt 1) : 631- 635.
  • 7曹贵华,吴小候,张尧,罗春丽.膀胱癌患者尿脱落细胞存活素表达的临床意义[J].中华泌尿外科杂志,2004,25(6):377-379. 被引量:21

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部